跳至主要内容
临床试验/NCT04592055
NCT04592055Unknown不适用

The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus

Uşak University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年3月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
A1c

研究概览

简要总结

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

详细描述

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

排除标准

  • The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

结局指标

主要结局

A1c

时间窗: 6 months (3 months before and after COVID-19

the change in A1c levels

次要结局

未报告次要终点

研究者

发起方
Uşak University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验